Lamotrigine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0228-1453
  • Package NDC 0228-1453-03
  • Application number ANDA200672
  • SPL ID 49ac5dcd-9ccd-4e5a-9fdd-fe22a79c2770
  • SPL set ID 87beaf22-593d-4170-bb58-332c615ef90d
  • UNII U3H27498KS
  • RxCUI 850087
  • RxCUI 850091
  • RxCUI 900156
  • RxCUI 900164
  • RxCUI 1098608
  • RxCUI 1146690

What the source publishes

Labeler
Actavis Pharma, Inc.
Active ingredients
Lamotrigine
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0228-1453_49ac5dcd-9ccd-4e5a-9fdd-fe22a79c2770
{
  "name": "Lamotrigine",
  "splId": "49ac5dcd-9ccd-4e5a-9fdd-fe22a79c2770",
  "labels": [
    {
      "setId": "87beaf22-593d-4170-bb58-332c615ef90d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87beaf22-593d-4170-bb58-332c615ef90d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=87beaf22-593d-4170-bb58-332c615ef90d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Actavis Pharma, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-1453-03)",
      "package_ndc": "0228-1453-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160401"
    }
  ],
  "productId": "0228-1453_49ac5dcd-9ccd-4e5a-9fdd-fe22a79c2770",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "0228-1453",
  "deaSchedule": null,
  "genericName": "Lamotrigine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAMOTRIGINE",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA200672",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753",
      "N0000008486",
      "N0000175751",
      "N0000187061",
      "N0000000191"
    ],
    "upc": [
      "0302281410036",
      "0302281435039"
    ],
    "unii": [
      "U3H27498KS"
    ],
    "rxcui": [
      "850087",
      "850091",
      "900156",
      "900164",
      "1098608",
      "1146690"
    ],
    "spl_set_id": [
      "87beaf22-593d-4170-bb58-332c615ef90d"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]",
      "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
      "Organic Cation Transporter 2 Inhibitors [MoA]",
      "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Actavis Pharma, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0228-1453_49ac5dcd-9ccd-4e5a-9fdd-fe22a79c2770"